Search / 40 results found

from
to
  • Updated

COLLIE, Western Australia and NEW YORK, Nov. 23, 2021 /PRNewswire/ -- Cannaponics Limited "Cannaponics", a licensed medicinal cannabis cultivation, manufacturing and research company, is pleased to announce a licensing partnership with New Age Nanotech, a provider of the leading clinically-backed drug delivery technology for cannabinoids, called Solutech™.

  • Updated

PETACH TIKVA, Israel and MELBOURNE, Australia, Nov. 9, 2021 /PRNewswire/ -- Peter MacCallum Cancer Centre, world leading cancer research, education and treatment center and Isotopia Molecular Imaging Limited (Isotopia), a global supplier of radioisotopes for targeted therapies, today announced they have signed a clinical research and supply agreement for the medical radioisotope no-carrier-added Terbium-161 (n.c.a. Tb-161), an innovative therapeutic isotope used for targeted cancer treatment.

  • Updated

ROCHESTER, N.Y., Nov. 2, 2021 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that The AVR Lab, a distributor of Vuzix smart glasses products to the Australian and New Zealand markets, has continued to place follow-on orders for Vuzix Smart Glasses. Customer use cases to date have included on-site inspection and maintenance, work instructions and remote technical support and on-the-job training.

  • Updated

NEW YORK, Nov. 2, 2021 /PRNewswire/ -- PUBLIC is a perpetual work in progress. It is in a constant state of improvement and will never be finished. The founding principle behind the brand and hotel is to offer the best, most original and exciting experience imaginable.